Author:
Wang Yu,Gu Yu-Hui,Ren Kai-Wen,Xie Xin,Wang Shi-Hao,Zhu Xiao-Xue,Wang Lei,Yang Xiao-Lei,Bi Hai-Lian
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Dan GA. Rhythm control in AF: Have we reached the last frontier? Eur Cardiol. 2019;14:77–81.
2. Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NAM. The state of the art: Atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc. 2016;91:1778–810.
3. Arbelo E, Brugada J, Blomström-Lundqvist C, Laroche C, Kautzner J, Pokushalov E, et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. Eur Heart J. 2017;38:1303–16.
4. Demers J, Ton AT, Huynh F, Thibault S, Ducharme A, Paradis P, et al. Atrial electrical remodeling in mice with cardiac-specific overexpression of Angiotensin II Type 1 receptor. J Am Heart Assoc. 2022;11:e023974.
5. Chen Y, Chen X, Li H, Li Y, Cheng D, Tang Y, et al. Serum extracellular vesicles containing MIAT induces atrial fibrosis, inflammation and oxidative stress to promote atrial remodeling and atrial fibrillation via blockade of miR-485-5p-mediated CXCL10 inhibition. Clin Transl Med. 2021;11:e482.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献